2024 annual financial data
enGene Therapeutics 2024 Net margin
Direct answer
Net margin was Not calculable.
Operating income was -62,297,000 USD and net income was -55,142,000 USD.
Operating cash flow was -48,281,000 USD.
Get free enGene Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -62,297,000 USD
- Net income
- -55,142,000 USD
- Operating cash flow
- -48,281,000 USD